OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Pharmaceuticals Promoting Premature Termination Codon Readthrough: Progress in Development
Shan Li, Juan Li, Wenjing Shi, et al.
Biomolecules (2023) Vol. 13, Iss. 6, pp. 988-988
Open Access | Times Cited: 12
Shan Li, Juan Li, Wenjing Shi, et al.
Biomolecules (2023) Vol. 13, Iss. 6, pp. 988-988
Open Access | Times Cited: 12
Showing 12 citing articles:
P53: A key player in diverse cellular processes including nuclear stress and ribosome biogenesis, highlighting potential therapeutic compounds
Gazmend Temaj, Silvia Chichiarelli, Pelin Telkoparan‐Akillilar, et al.
Biochemical Pharmacology (2024) Vol. 226, pp. 116332-116332
Closed Access | Times Cited: 5
Gazmend Temaj, Silvia Chichiarelli, Pelin Telkoparan‐Akillilar, et al.
Biochemical Pharmacology (2024) Vol. 226, pp. 116332-116332
Closed Access | Times Cited: 5
Genome-scale quantification and prediction of pathogenic stop codon readthrough by small molecules
Ignasi Toledano, Fran Supek, Ben Lehner
Nature Genetics (2024) Vol. 56, Iss. 9, pp. 1914-1924
Open Access | Times Cited: 5
Ignasi Toledano, Fran Supek, Ben Lehner
Nature Genetics (2024) Vol. 56, Iss. 9, pp. 1914-1924
Open Access | Times Cited: 5
Combinatorial biosynthesis of novel gentamicin derivatives with nonsense mutation readthrough activity and low cytotoxicity
Lihua Yang, Hang Zhai, Tingting Tian, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Lihua Yang, Hang Zhai, Tingting Tian, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Human disease-causing mutations result in loss of leiomodin 2 through nonsense-mediated mRNA decay
Christopher T. Pappas, Rachel M. Mayfield, Ava E. Dickerson, et al.
PLoS Genetics (2024) Vol. 20, Iss. 5, pp. e1011279-e1011279
Open Access | Times Cited: 3
Christopher T. Pappas, Rachel M. Mayfield, Ava E. Dickerson, et al.
PLoS Genetics (2024) Vol. 20, Iss. 5, pp. e1011279-e1011279
Open Access | Times Cited: 3
Restoring susceptibility to aminoglycosides: identifying small molecule inhibitors of enzymatic inactivation
Angel J. Magaña, Jan Sklenicka, Clemencia Pinilla, et al.
RSC Medicinal Chemistry (2023) Vol. 14, Iss. 9, pp. 1591-1602
Closed Access | Times Cited: 8
Angel J. Magaña, Jan Sklenicka, Clemencia Pinilla, et al.
RSC Medicinal Chemistry (2023) Vol. 14, Iss. 9, pp. 1591-1602
Closed Access | Times Cited: 8
Identification of novel small molecule-based strategies of COL7A1 upregulation and readthrough activity for the treatment of recessive dystrophic epidermolysis bullosa
Irene Jover, María C. Ramos, M.J. Escámez, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Irene Jover, María C. Ramos, M.J. Escámez, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
ELX-02 Suppresses Nonsense Mutations and Restores Type VII Collagen and Laminin 332 Function in Recessive Dystrophic and Junctional Epidermolysis Bullosa
Brandon Levian, Yingping Hou, Xin Tang, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 4, pp. 102334-102334
Open Access | Times Cited: 1
Brandon Levian, Yingping Hou, Xin Tang, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 4, pp. 102334-102334
Open Access | Times Cited: 1
Readthrough Approach Using NV Translational Readthrough-Inducing Drugs (TRIDs): A Study of the Possible Off-Target Effects on Natural Termination Codons (NTCs) on TP53 and Housekeeping Gene Expression
Riccardo Perriera, Emanuele Vitale, Ivana Pibiri, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15084-15084
Open Access | Times Cited: 2
Riccardo Perriera, Emanuele Vitale, Ivana Pibiri, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15084-15084
Open Access | Times Cited: 2
Aminoglycoside Induced Nephrotoxicity: Pharmacokinetics, Epidemiology, Risk Factors, Pathogenesis, and Prevention
Chelsi J. Flanagan, Alexander J. Golden, Lily Choi, et al.
Elsevier eBooks (2024)
Closed Access
Chelsi J. Flanagan, Alexander J. Golden, Lily Choi, et al.
Elsevier eBooks (2024)
Closed Access
Anticodon Engineered Transfer RNAs (ACE-tRNAs) are a Platform Technology for Suppressing Nonsense Mutations
Wooree Ko, Joseph J. Porter, Sacha Spelier, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Wooree Ko, Joseph J. Porter, Sacha Spelier, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Potentiation by Protein Synthesis Inducers of Translational Readthrough of Pathogenic Premature Termination Codons in PTEN Isoforms
Leire Torices, Caroline E. Nunes‐Xavier, Rafael Pulido
Cancers (2024) Vol. 16, Iss. 16, pp. 2836-2836
Open Access
Leire Torices, Caroline E. Nunes‐Xavier, Rafael Pulido
Cancers (2024) Vol. 16, Iss. 16, pp. 2836-2836
Open Access
Misincorporations of amino acids in p53 in human cells at artificially constructed termination codons in the presence of the aminoglycoside Gentamicin
Kamila Pawlicka, Tomas Henek, Lukáš Uhrík, et al.
Frontiers in Genetics (2024) Vol. 15
Open Access
Kamila Pawlicka, Tomas Henek, Lukáš Uhrík, et al.
Frontiers in Genetics (2024) Vol. 15
Open Access
Engineered tRNAs efficiently suppress CDKL5 premature termination codons
Stefano Pezzini, Aurora Mustaccia, Pierre Aboa, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Stefano Pezzini, Aurora Mustaccia, Pierre Aboa, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
